4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001628280-22-005790
Options or other derivatives
- Chief Executive Officer acquired 370,128 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Erlander Mark Chief Executive Officer | 2022-03-09 | Grant or award · Stock Options | +370,128 | 1,185,400 | D | ||
Loading xslF345X03/wf-form4_164695553669989.xml…